Recent ARVN News
- Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer • GlobeNewswire Inc. • 06/24/2024 08:37:13 PM
- Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2 • GlobeNewswire Inc. • 06/21/2024 11:00:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:53:30 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 09:51:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:55:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 11:03:14 AM
- Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angela Cacace, Ph.D. to Chief Scientific Officer • GlobeNewswire Inc. • 06/17/2024 11:00:03 AM
- Arvinas to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 06/03/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 09:52:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:52:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 01:48:00 AM
- Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress • GlobeNewswire Inc. • 05/23/2024 09:00:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 10:05:26 AM
- Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®) • GlobeNewswire Inc. • 05/16/2024 10:00:45 AM
- Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress • GlobeNewswire Inc. • 05/09/2024 08:42:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:13:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 11:02:45 AM
- Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/07/2024 11:00:11 AM
- Arvinas to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer • GlobeNewswire Inc. • 04/24/2024 08:30:38 PM
- Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer • GlobeNewswire Inc. • 04/11/2024 11:00:49 AM
- Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer • GlobeNewswire Inc. • 03/18/2024 08:40:46 PM
- Arvinas to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/04/2024 12:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:35:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:34:14 PM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM